INTRODUCTION Aneurysmal degeneration can occur anywhere in the human aorta. By definition, an aneurysm is a localized or diffuse dilation of an artery with a diameter at least 50% greater then the normal size of the artery. The vast majority of aortic aneurysms (AAs) occur in the abdominal aorta. These are termed abdominal AAs (AAAs). Although most AAAs are asymptomatic at the time of diagnosis, the most common complication remains life-threatening rupture with hemorrhage. Aneurysmal degeneration that occurs in the thoracic aorta is termed a thoracic aneurysm (TA). Aneurysms that coexist in both segments of the aorta (thoracic and abdominal) are termed thoracoabdominal aneurysms (TAAs). TAs and TAAs are also at risk for rupture. Thoracic AAs are subdivided into 3 groups depending on location: ascending aortic, aortic arch, and descending TAs or TAAs. Aneurysms involving the ascending aorta may extend as proximally as the aortic annulus and as distally as the innominate artery, whereas descending TAs begin beyond the left subclavian artery. Arch aneurysms are as the name implies. Dissection is another condition that may affect the thoracic aorta. A false passage for blood develops between the layers of the aorta. This false passage may extend into branches of the aorta in the chest or abdomen, causing ischemia or occlusion with resultant complications. Dissection can also lead to aneurysmal change and early or late rupture. Dissection should not be termed dissecting aneurysm because it can occur with or without aneurysmal enlargement of the aorta. Treatment of AAAs, TAAs, and TAs involves surgical repair in good-risk patients with aneurysms that have reached a size sufficient to warrant repair. History of the Procedure: The development of treatment modalities for TAs followed successful treatment of AAAs. Estes' 1950 report revealed that the 3-year survival rate for patients with untreated AAAs was only 50%, with two thirds of deaths resulting from aneurysmal rupture. Since then, increased attempts were made to devise methods of durable repair. Most of these initial successful repairs involved the use of preserved aortic allografts, thus triggering the establishment of numerous aortic allograft banks. Simultaneously, Gross and colleagues successfully used allografts to treat complex thoracic aortic coarctations, including those with aneurysmal involvement. In 1951, Lam and Aram reported the resection of a descending TA with allograft replacement. Ascending aortic replacement required the development of cardiopulmonary bypass and was first performed in 1956 by Cooley and De Bakey. They successfully replaced the ascending aorta with an aortic allograft. Successful replacement of the aortic arch, with its inherent risk of cerebral ischemia, was understandably more challenging and was not reported until 1957 by De Bakey et al. Although the use of aortic allografts as aortic replacement was widely accepted in the early 1950s, the search for synthetic substitutes was well underway. Dacron was introduced by De Bakey. By 1955, Deterling and Bhonslay believed that Dacron was the best material for aortic substitution. Numerous types of intricately woven hemostatic grafts have since been developed and are now used much more extensively than their allograft counterparts. Subsequently, combined operations replacing the ascending aneurysm in conjunction with replacement of the aortic valve and reimplantation of the coronary arteries were performed by Wheat et al in 1964, Bentall and De Bono in 1968, and Wheat et al in 1971. Problem: Aneurysms are usually defined as a localized dilation of an arterial segment greater that 50% its normal diameter. The majority of AAs occur in the infrarenal segment (95%). The average size for an infrarenal aorta is 2 cm; therefore, AAAs are usually defined by diameters greater than 3 cm. The normal size for the thoracic and thoracoabdominal aorta is larger
than that of the infrarenal aorta, and aneurysmal degeneration in these
areas is defined accordingly. The average diameter of the mid-descending
thoracic aorta is 26-28 mm, compared with 20-23 mm at the level of the
celiac axis.
Frequency: Although findings from autopsy series vary widely, the prevalence of AAs probably exceeds 3-4% in individuals older than 65 years. Death from aneurysmal rupture is one of the 15 leading causes of death in most series. The estimated incidence of thoracic AAs is 6 cases per 100,000 person-years. In addition, the overall prevalence of AAs has increased significantly in the last 30 years. This is partly due to an increase in diagnosis based on the widespread use of imaging techniques. However, the prevalence of fatal and nonfatal rupture has also increased, suggesting a true increase in prevalence. An aging population probably plays a significant role. Etiology: Aneurysmal degeneration occurs more commonly in the aging population. Aging results in changes in collagen and elastin, which lead to weakening of the aortic wall and aneurysmal dilation. According to the Laplace law, luminal dilation results in increased wall tension and the vicious cycle of progressive dilation and greater wall stress. Pathologic sequelae of the aging aorta include elastic fiber fragmentation and cystic medial necrosis. Arteriosclerotic (degenerative) disease is the most common cause of TAs. A previous aortic dissection with a persistent false channel may produce aneurysmal dilation; such aneurysms are the second most common type. False aneurysms are more common in the descending aorta and arise from the extravasation of blood into a tenuous pocket contained by the aortic adventitia. Because of increasing wall stress, false aneurysms tend to enlarge over time. Authorities strongly agree that genetics play a role in the formation of AAs. Of first-degree relatives of patients with AAs, 15% have an aneurysm. This appears especially true in first-degree relatives of female patients with AAs. Thus, inherited disorders of connective tissue appear to contribute to the formation of AAs. Marfan syndrome is a potentially lethal connective-tissue disease characterized by skeletal, heart valve, and ocular abnormalities. Individuals with this disease are at risk for aneurysmal degeneration, especially in the thoracic aorta. Marfan syndrome is an autosomal dominant genetic condition that results in abnormal fibrillin, a structural protein found in the human aorta. Patients with Marfan syndrome may develop annuloaortic ectasia of the sinuses of Valsalva, commonly associated with aortic valvular insufficiency and aneurysmal dilation of the ascending aorta. Type IV Ehlers-Danlos syndrome results in a deficiency in the production of type III collagen, and individuals with this disease may develop aneurysms in any portion of the aorta. Imbalances in the synthesis and degradation of structural proteins of the aorta have also been discovered, which may be inherited or spontaneous mutations. Atherosclerosis may play a role. Whether atherosclerosis contributes to the formation of an aneurysm or whether they occur concomitantly is not established. Other causes of AAs are infection (ie, bacterial [mycotic or syphilitic]), arteritis (ie, Takayasu), and trauma. Aortitis due to granulomatous disease is rare, but it can lead to the formation of aortic and, on occasion, pulmonary artery aneurysms. Aortitis caused by syphilis may cause destruction of the aortic media followed by aneurysmal dilation. The true etiology of AAs is probably multifactorial, and the condition
occurs in individuals with multiple risk factors. Risk factors include
smoking, hypertension, atherosclerosis, bicuspid or unicuspid aortic
valves, and genetic disorders. AAs are more common in men than in women
and are more common in persons with chronic obstructive pulmonary disease
than in those without the lung disease.
Pathophysiology: The occurrence and expansion of an aneurysm in a given segment of the arterial tree probably involves local hemodynamic factors and factors intrinsic to the arterial segment itself. The medial layer of the aorta is responsible for much of its tensile strength and elasticity. Multiple structural proteins comprise the normal medial layer of the human aorta. Of these, collagen and elastin are probably the most important. The elastin content of the ascending aorta is high and diminishes progressively in the descending thoracic and abdominal aorta. The infrarenal aorta has a relative paucity of elastin fibers in relation to collagen and compared with the thoracic aorta, possibly accounting for the increased frequency of aneurysms in this area. In addition, the activity and amount of specific enzymes is increased, which leads to the degradation of these structural proteins. Elastic fiber fragmentation and loss with degeneration of the media result in weakening of the aortic wall, loss of elasticity, and consequent dilation. Hemodynamic factors probably play a role in the formation of AAs. The human aorta is a relatively low-resistance circuit for circulating blood. The lower extremities have higher arterial resistance, and the repeated trauma of a reflected arterial wave on the distal aorta may injure a weakened aortic wall and contribute to aneurysmal degeneration. Systemic hypertension compounds the injury, accelerates the expansion of known aneurysms, and may contribute to their formation. Hemodynamically, the coupling of aneurysmal dilation and increased wall stress is defined by the Laplace law. Specifically, the Laplace law states that the (arterial) wall tension is proportional to the pressure times the radius of the arterial conduit (T = P X R). As diameter increases, wall tension increases, which contributes to increasing diameter. As tension increases, risk of rupture increases. Increased pressure (systemic hypertension) and increased aneurysm size aggravate wall tension and therefore increase the risk of rupture. Aneurysm formation is probably the result of multiple factors affecting that arterial segment and its local environment. Clinical: Most patients with AAs are asymptomatic at the time of discovery. TAs are usually found incidentally after chest radiographs or other imaging studies. AAAs may be discovered incidentally during imaging studies or a routine physical examination as a pulsatile abdominal mass. The most common complication of AAAs is rupture with life-threatening hemorrhage manifesting as pain and hypotension. The triad of abdominal pain, hypotension, and a pulsatile abdominal mass is diagnostic of a ruptured AAA, and emergent operation is warranted without delay for imaging studies. Patients with a variant of AAA may present with fever and a painful aneurysm with or without an obstructive uropathy. These patients may have an inflammatory aneurysm that can be treated with surgical repair. Patients with TAs are often asymptomatic. Most patients are hypertensive but remain relatively asymptomatic until the aneurysm expands. Their most common presenting symptom is pain. Pain may be acute, implying impending rupture or dissection, or chronic, from compression or distension. The location of pain may indicate the area of aortic involvement, but this is not always the case. Ascending AAs tend to cause anterior chest pain, while arch aneurysms more likely cause pain radiating to the neck. Descending TAs more likely cause back pain localized between the scapulae. When located at the level of the diaphragmatic hiatus, the pain occurs in the mid back and epigastric region. Large ascending AAs may cause superior vena cava obstruction manifesting as distended neck veins. Ascending AAs also may develop aortic insufficiency, with widened pulse pressure or a diastolic murmur. Arch aneurysms may cause hoarseness, which results from stretching of the recurrent laryngeal nerves. Descending TAs and TAAs may compress the trachea or bronchus and cause stridor, wheezing, or cough. Compression of the esophagus results in dysphagia. Erosion into surrounding structures may result in hemoptysis, hematemesis, or gastrointestinal bleeding. Erosion into the spine may cause back pain or instability. Spinal cord compression or thrombosis of spinal arteries may result in neurologic symptoms of paraparesis or paraplegia. Descending TAs may thrombose or embolize clot and atheromatous debris distally to visceral, renal, or lower extremities. Patients who present with ecchymoses and petechiae may be particularly challenging because these signs probably indicate disseminated intravascular coagulation. The risk of significant perioperative bleeding is extremely high, and large amounts of blood and blood products must be available for resuscitative transfusion. The most common complications of thoracic AAs are acute rupture or dissection. Some patients present with tender or painful nonruptured aneurysms. Although debate continues, these patients are thought to be at increased risk for rupture and should undergo surgical repair on an emergent basis.
INDICATIONS Indications for surgery of thoracic AAs are based on size or growth rate and symptoms. Because the risk of rupture is proportional to the diameter of the aneurysm, aneurysmal size is the criterion for elective surgical repair. Elefteriades published the natural history of thoracic AAs and recommends elective repair of ascending aneurysms at 5.5 cm and descending aneurysms at 6.5 cm for patients without any familial disorders such as Marfan syndrome. Patients with Marfan syndrome or familial aneurysms should undergo earlier repair, when the ascending aorta grows to 5 cm or the descending aorta grows to 6 cm. Rapid expansion is also a surgical indication. Growth rates average 0.07 cm/y in the ascending aorta and 0.19 cm/y in the descending aorta. A growth rate of 1 cm/y or faster is an indication for elective surgical repair. Symptomatic patients should undergo aneurysm resection regardless of size. Acutely symptomatic patients require emergent operation. Emergent operation is indicated in the setting of acute rupture. Rupture of the ascending aorta may occur into the pericardium, resulting in acute tamponade. Rupture of the descending thoracic aorta may cause a left hemothorax. Patients with acute aortic dissection of the ascending aorta require emergent operation. They may present with rupture, tamponade, acute aortic insufficiency, myocardial infarction, or end organ ischemia. Acute dissection of the descending aorta does not require surgical intervention, unless complicated by rupture, malperfusion, progressive dissection, or failure of medical management. Patients who undergo surgery for symptomatic aortic insufficiency or
stenosis with an associated enlarged (questionably aneurysmal) aorta
should have concomitant aortic replacement if the aorta exceeds 4-5 cm in
diameter.
RELEVANT ANATOMY AND CONTRAINDICATIONS Relevant Anatomy: Ascending AAs occur as proximally as the aortic annulus and as distally as the innominate artery. They may compress or erode into the sternum, causing pain or fistula. They also may compress the superior vena cava or airway. When symptomatic by rupture or dissection, they may involve the pericardium, aortic valve, or coronary arteries. They may rupture into the pericardium, causing tamponade. They may dissect into the aortic valve, causing aortic insufficiency, or into the coronary arteries, causing myocardial infarction. Aortic arch aneurysms involve the aorta where the innominate artery, left carotid, and left subclavian originate. They may compress the innominate vein or airway. They may stretch the left recurrent laryngeal nerve, causing hoarseness. Descending TAs originate beyond the left subclavian artery and may extend into the abdomen. TAAs are stratified based on the Crawford classification. Type I involves the descending thoracic aorta from the left subclavian artery down to the abdominal aorta above the renal arteries. Type II extends from the left subclavian artery to the renal arteries and may continue distally to the aortic bifurcation. Type III begins at the mid-to-distal descending thoracic aorta and involves most of the abdominal aorta as far distal as the aortic bifurcation. Type IV extends from the upper abdominal aorta and all or none of the infrarenal aorta. Descending TAs and TAAs may compress or erode into surrounding structures, including the trachea, bronchus, esophagus, vertebral body, and spinal column. Contraindications: Aneurysm surgery has no strict contraindications. The relative contraindications are individualized, based on the patient's ability to undergo extensive surgery (ie, the risk-to-benefit ratio). Patients at higher risk for morbidity and mortality include elderly persons and individuals with end-stage renal disease, respiratory insufficiency, cirrhosis, or other comorbid conditions. |
||||||
WORKUP Lab Studies:
Imaging Studies:
Other Tests:
Diagnostic Procedures:
TREATMENT Medical therapy: All aneurysms must be treated with risk-factor reduction. Systemic hypertension probably contributes to the formation of aneurysms and certainly contributes to expansion and rupture. This is especially true of TAs. Strict control of hypertension is implemented in all patients, regardless of AA size. Tobacco use contributes to aneurysm formation, although the exact pathophysiology is not well understood. Cessation of smoking is recommended. Control of other risk factors for peripheral arterial obstructive disease may be beneficial. Surgical therapy: Most aneurysm repairs involve aortic replacement with a Dacron tube graft. Dacron grafts allow ingrowth in the interstices to form a pseudoendothelial layer to minimize the risk of embolization. They may be knitted or woven. Knitted grafts are more porous and incorporate tissue well; however, they are prone to more bleeding. Woven grafts are more impervious and therefore are the most commonly used for aortic replacement. Grafts are typically impregnated with collagen to avoid preclotting the graft and to promote optimal healing. Ascending AAs Surgical treatment of ascending aortic aneurysms depends on the extent of the aneurysm both proximally, ie, involvement of the aortic valve, annulus, sinuses of Valsalva, or sinotubular junction, and distally, ie, involvement to the level of the innominate artery. Ascending aorta aneurysms with a healthy aortic valve, annulus, and sinuses of Valsalva are typically replaced with a simple Dacron tube graft from the sinotubular junction to the origin of the innominate artery, with the patient under cardiopulmonary bypass. Sinus of Valsalva aneurysms with normal aortic valve leaflets and aortic insufficiency due to dilated sinuses may be repaired with valve-sparing aortic root replacements. Two valve-sparing procedures have been developed and include the remodeling method and the reimplantation method. The remodeling method involves resecting the aneurysmal sinus tissue while maintaining the tissue along the valve leaflets and scalloping the Dacron graft to form new sinuses to remodel the root. The reimplantation method involves reimplanting the scalloped native valve into the Dacron graft. Both require reimplantation of the coronary ostia. Patients with an abnormal aortic valve and aortic root require aortic root replacement. In nonelderly patients, who can undergo anticoagulation with reasonable safety, the aortic root may be replaced with a composite graft consisting of a mechanical valve inserted into a Dacron graft. For elderly patients, young active patients who do not desire anticoagulation, women of childbearing age, and patients with contraindications to warfarin, the options include stentless porcine roots, aortic homografts, and pulmonary autografts. Marfan syndrome patients have abnormal aortas and do not undergo tube graft replacement alone. They must have either a valve-sparing aortic root replacement or a complete aortic root replacement. Aortic arch aneurysms Arch aneurysms pose a formidable technical challenge. Deep hypothermic circulatory arrest (HCA) with or without antegrade or retrograde cerebral perfusion is usually used to facilitate reanastomosis of the arch vessels. Aortic arch reconstruction techniques vary depending on the arch pathology. In patients with proximal arch involvement extending from the ascending aorta, a hemiarch replacement may be performed. The ascending aorta is replaced with a Dacron graft beveled as a tongue along the undersurface of the arch. In patients whose conditions mandate replacement of the entire arch, the distal anastomosis is the Dacron graft to the descending thoracic aorta. The head vessels are reimplanted individually or as an island. Grafts have been developed with a trifurcated head-vessel attachment and with a fourth attachment for the cannula. In this case, the head vessels are attached individually to the trifurcated branches. For patients in whom the arch replacement is part of a staged procedure, preceding the delayed repair of a concomitant descending TA, an “elephant trunk” is used. That is, the Dacron graft used to replace the arch ends distally in an extended sleeve that is telescoped into the descending thoracic aorta, facilitating later replacement of the descending TA. Descending thoracic AAs and TAAs Descending TAs may be repaired with or without the use of a bypass from the left atrial artery to the femoral artery or full cardiopulmonary bypass, depending on the length of the anticipated ischemic cross-clamping and the experience of the surgeon. Discreet aneurysms with an anticipated clamp time of less than 30 minutes may be repaired without partial or full bypass. More complex or larger aneurysms are probably more safely repaired with the aid of either partial or full cardiopulmonary bypass. TAAs, comprising approximately 10% of TAs, may be repaired with the use of a partial bypass of the left atrial artery to the femoral artery. Crawford type I TAAs involve Dacron graft replacement of the aorta from the left subclavian artery to the visceral and renal arteries as a beveled distal anastomosis, using sequential cross-clamping of the aorta. Crawford type II TAA repair requires a Dacron graft from the left subclavian to the aortic bifurcation with reattachment of the intercostal arteries, visceral arteries, and renal arteries. Crawford type III or IV TAA repairs, which begin lower along the thoracic aorta or upper abdominal aorta, may use either the partial bypass of the left atrial artery to the femoral artery or a modified atriovisceral and/or renal bypass. Prevention of paraplegia is one of the principal concerns in the repair of descending and TAAs. Preoperative details: Ascending AA Preoperative assessment of coronary artery disease is essential to determine the need for concomitant coronary artery bypass grafting. Transesophageal echocardiography is crucial preoperatively to examine the need for aortic valve replacement. Patients with aortic stenosis or aortic insufficiency in whom the valve leaflets are anatomically abnormal require replacement, whereas patients with aortic insufficiency and normal aortic valve leaflets may be candidates for valve-sparing procedures. Transesophageal echocardiography is valuable for accurate delineation of the aortic root at the sinuses of Valsalva and sinotubular junction. Aortic arch aneurysm The major morbidities from aortic arch aneurysm repair are neurologic, cardiac, and pulmonary in nature. All patients require preoperative assessment of cardiac function and evaluation for coronary artery disease. In the operating room, transesophageal echocardiography is used to monitor ventricular function and to assess for atherosclerosis of the aorta. A major concern in arch surgery is neurologic injury, both transient neurologic dysfunction and permanent neurologic injury. Patients with a higher risk of stroke undergo preoperative noninvasive carotid ultrasound, and those with a history of stroke undergo a brain CT scan. In the operating room, steroids are often given at the onset of the procedure if HCA is anticipated. Evidence suggests that steroids given preoperatively several hours before the operation may have benefit. Some institutions monitor electroencephalogram silence to assess for adequate duration and temperature of cerebral cooling for HCA. Descending TAs and TAAs A devastating complication of descending TA and TAA repair is spinal cord injury with paraparesis or paraplegia. Preoperatively, some groups perform spinal arteriograms to attempt to localize the artery of Adamkiewicz for reimplantation during surgery. Neurologic monitoring with somatosensory evoked potentials or motor evoked potentials is used by some to assess spinal cord ischemia and identify critical segmental arteries for spinal cord perfusion. Lastly, preoperative placement of catheters for cerebrospinal fluid drainage is performed to increase spinal cord perfusion pressure during aortic cross-clamping. Intraoperative details:
Ascending AAsAscending aortic replacement Cardiopulmonary bypass is established and the aorta is cross-clamped just below the innominate artery. The heart is arrested with cardioplegia. The aorta is transected at the sinotubular junction and sized for the appropriate Dacron tube graft. The tube graft is sutured to the proximal aorta with running 4-0 Prolene with a strip of felt. The tube graft is measured to length distally and sutured to the distal aorta using running 4-0 Prolene with a strip of felt. Valve-sparing aortic root replacement Once the aorta is transected at the sinotubular junction, the valve is inspected for normal anatomy. If sparing is feasible, the appropriate size tube graft is chosen to allow coaptation of the aortic valve leaflets without aortic insufficiency. In the remodeling technique, the tube graft is tailored to form aortic sinuses. The sinuses of Valsalva of the native aorta are removed, and the coronary ostia are mobilized. The neosinuses of the tube graft are sutured to the scalloped aortic valve with running 4-0 Prolene and a strip of felt. In the reimplantation technique, Tycron sutures are placed along the subannular horizontal plane and passed through the tube graft. The scalloped aortic valve is placed within the tube graft, and the proximal suture line is secured. The scalloped aortic valve is positioned in the graft to achieve valve competence, and the subcoronary suture line along the scalloped valve is performed with running 4-0 Prolene. The valve is examined for competence within the graft. The coronary ostia are reimplanted in the graft. The graft is measured to length distally and sutured to the distal aorta. Aortic root replacement The aorta is transected, and the aortic valve is removed. The annulus is sized, and the appropriate valved conduit, stentless root, mechanical composite, or homograft is brought to the field. The coronary ostia are mobilized. Annular sutures are placed and are passed through the valve conduit. The proximal suture is thus secured. The coronary ostia are reimplanted. The distal suture line is performed for the mechanical valve composite, but an additional Dacron graft extension may be required for the stentless roots or homografts, depending on their length. Open distal anastomosis HCA with or without antegrade or retrograde cerebral perfusion is used. When cooled to 18°C (64.4°F), the pump is turned off and the arterial line is clamped. The patient is placed in the Trendelenburg position, and the aortic cross clamp is removed. The distal anastomosis is performed open with running 4-0 Prolene and a strip of felt. The distal anastomosis may be at the level of the innominate artery or, in the case of hemiarch replacement, along the undersurface of the arch to the level of the left subclavian artery. Once complete, the pump is restarted with blood flow antegrade into the new graft and open proximal tube graft to flush out air and debris. The graft is then clamped. The proximal aorta and root are then addressed during rewarming. The risk of air embolism is reduced by flooding the surgical field with
carbon dioxide. In the past, carbon dioxide was used intravascularly;
however, it is more commonly applied in the field today. Carbon dioxide is
denser than air and displaces air. Any carbon dioxide absorbed in the
blood is removed by increasing the sweep speed of cardiopulmonary bypass.
Aortic arch aneurysm repairsCannulation for arch repairs varies among groups. They include the femoral artery, right axillary artery, and ascending aorta. HCA is required for arch repairs, but the safe period of arrest to avoid neurologic injury is 40-60 minutes at 18°C (64.4°F), but some advocate a shorter period of 25 minutes. Antegrade cerebral perfusion to minimize neurologic injury is thus advocated. Others advocate cooling to 11-14°C (51.8-57.2°F). Once the patient is cooled to the desired temperature, the circuit is
turned off. For retrograde cerebral perfusion, flow is established through
the superior vena cava as the arch reconstruction is performed. For
antegrade cerebral perfusion, flow is continued through the axillary
artery with the innominate artery clamped or individual perfusion
catheters are placed into the innominate artery, left carotid artery, and
left subclavian arteries. The arch reconstructions are also varied. They
basically involve performing the distal anastomosis to the aorta beyond
the left subclavian artery as an open distal procedure with or without an
elephant trunk. The 3 head vessels may be reanastomosed individually or as
an island. They may be reimplanted directly to the graft or anastomosed to
a separate graft, which is then attached to arch graft.
Descending TA and TAA repairsMeasures to reduce spinal cord injury include cerebrospinal fluid drainage, reimplantation of intercostal arteries, partial bypass, and mild hypothermia. A left thoracotomy or a thoracoabdominal incision is performed. The aorta is cross-clamped either just beyond the left subclavian or between the left carotid and left subclavian for Crawford types I and II. The cross clamp is placed more distally for Crawford types III and IV. Atrial femoral bypass is established with a Bio-Medicus circuit, and the patient is cooled to 32-34°C (89.6-93.2°F). Distal cross-clamping is performed at T4-T7 to allow continued spinal cord, visceral, and renal perfusion. The proximal anastomosis is performed with running 4-0 Prolene and a strip of felt. When complete, the proximal clamp is released and reapplied more distally on the tube graft. The distal cross clamp is moved sequentially down, if feasible, to allow visceral and renal perfusion, while the intercostal arteries are reimplanted. If sequential cross-clamping is not feasible, direct catheters may be placed in the visceral and renal vessels to allow continuous perfusion. If the distal aneurysm extends to the renals, then the distal anastomosis may be beveled to incorporate the visceral and renal vessels and distal aorta. If the distal aneurysm extends to the bifurcation, the visceral and renal vessels are reattached to the tube graft. The left renal artery typically requires a separate anastomosis, but the celiac, superior mesenteric, and right renal arteries are often incorporated as a single island. The patient is rewarmed, and the partial bypass is discontinued as the tube graft perfuses the intercostals and abdominal vessels. The distal anastomosis at the bifurcation is performed as an open distal procedure. Postoperative details: Patients who have undergone ascending aneurysm repairs are observed for signs of coronary ischemia, particularly if the coronary ostia were reimplanted, and for signs of aortic insufficiency when the aortic valve is repaired. Following the repair of arch aneurysms, particular attention must be given to neurological status, and patients who have had the elephant trunk repair must be observed for signs of paraplegia because the telescoped sleeve in the descending aorta may obstruct critical spinal vessels. Paraplegia is the main concern in patients who have had repair of the descending and thoracoabdominal aorta. Cerebrospinal fluid drainage may be continued for up to 72 hours postoperatively if necessary, along with motor evoked potential monitoring. Paraplegia and paraparesis may be acute or delayed postoperatively. If paraparesis or paraplegia is delayed, increased mean arterial pressure with pressors and reinstitution of cerebrospinal fluid drainage may augment spinal cord perfusion to reverse this complication. Paraplegia due to occlusion of critical spinal arteries that were not reimplanted cannot be reversed by these maneuvers. Acute postoperative renal dysfunction may be due to extended periods of ischemic cross-clamping or to HCA. Follow-up care: Development of another aneurysm postoperatively is not uncommon in these patients. For this reason, serial evaluations (ie, CT scans or MRI for ascending, arch, or descending aneurysms; echocardiography for ascending aneurysms) may be performed every 3-6 months during the first postoperative year and every 6 months thereafter
COMPLICATIONS Bleeding is a potential complication for all aneurysm repairs. It is minimized by the use of antifibrinolytics, felt strips, and factors, including fresh frozen plasma and platelets. For patients who undergo HCA, the use of aprotinin is controversial, but most groups routinely use aminocaproic acid (Amicar). Coagulopathy and bleeding in severe cases may warrant the use of factor VII. Stroke is a major cause of morbidity and mortality and typically results from embolization of atherosclerotic debris or clot. Transesophageal echocardiography and epiaortic ultrasound may be beneficial in localizing appropriate areas to clamp. Patients undergoing arch repairs are at the highest risk of permanent and transient neurologic injury. Retrograde cerebral perfusion is beneficial for flushing out embolic debris, but it may be detrimental, with increased intracranial pressure and cerebral edema. Antegrade cerebral perfusion is beneficial for reducing neurologic injury during HCA. Myocardial infarction may occur with technical problems with coronary ostia implantation during root replacement for ascending AAs and may require reoperation. Pulmonary dysfunction and renal dysfunction are other potentially morbid complications. Paraparesis and paraplegia, either acute or delayed, are the most
devastating complications of descending TA and TAA repairs. Despite
cerebrospinal drainage, reimplantation of intercostals, evoked potential
monitoring, mild hypothermia, and atrial femoral bypass, spinal cord
injury still occurs.
OUTCOME AND PROGNOSIS According to Culliford et al from 1982, Cabrol et al from 1988, and Donaldson and Ross from 1982, the early hospital mortality rate following repair of ascending aneurysms is 4-10%. As would be expected, the early mortality rate after repair of arch aneurysms is considerably higher, approaching 25% in series by Crawford and Saleh from 1981, Crawford et al from 1979, Columbi et al from 1983, Ergin et al from 1982, and Galloway et al from 1989. The rate after repair of descending TAs is lower, approximately 5-15%, according to Crawford et al from 1981, Donahoo et al from 1977, Livesay et al from 1985, and Pressler and McNamara from 1985. As a group, including all repairs, according to Crawford et al from
1978, Crawford et al from 1981, and Kitamura et al from 1983, survival
rates after surgery for chronic AAs are approximately 60% at 5 years and
30-40% at 10 years.
FUTURE AND CONTROVERSIES Ascending AA repair has been well established and is performed safely with low morbidity and mortality. The controversies lie in the use of valve-sparing root replacements in patients with Marfan syndrome with regard to the durability of the repair. However, because most patients with Marfan undergo the operation while they are young, they likely require reoperation eventually and the additional years of sparing their native aortic valve and living without anticoagulation are valuable. Arch aneurysms still carry the most morbidity and mortality because neurologic injury is a great risk. Most controversies involve the methods of cerebral protection. More and more evidence suggests that antegrade cerebral perfusion is an optimal choice to reduce both temporary and permanent neurologic injury. Recent advances in the treatment of descending TAs and TAAs have used endovascular stent grafting. They offer a less invasive alternative to open surgical repair. They are typically offered to patients who carry substantial operative risk, such as those with poor cardiac function, with compromised pulmonary or renal function, or of advanced age. Long-term results are pending. Aneurysms are the most commonly diagnosed conditions of the thoracic aorta that require surgery. Recently, many advances in aortic substitutes, cerebral protection, and perioperative care have led to improved survival rates and outcomes. | ||||||